European shares extend losses as virus worries offset vaccine cheer
Reuters
Published Nov 18, 2020 03:24AM ET
(Reuters) - European stocks slipped on Wednesday as worries about further economic damage and fresh lockdown measures caused by a resurgent pandemic dented recent optimism over promising vaccine trial results.
The pan-European STOXX 600 (STOXX) extended losses for a second session after dropping 0.4% by 0805 GMT.
Real estate (SX86P) and energy stocks (SXEP) fell the most, while tech stocks (SX8P) advanced.
Britain's RSA Insurance (L:RSA) rose 3.8% to the top of the STOXX 600 index after the company said it had received a cash offer worth 7.2 billion pounds ($9.55 billion) from Canadian peer Intact Financial (TO:IFC) and Danish insurer Tryg (CO:TRYG).
Deutsche Boerse (DE:DB1Gn) gained 0.8% after the German stock exchange operator said it would acquire an 80% stake in corporate governance adviser Institutional Shareholder Services (ISS) for about $1.8 billion.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.